Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF)

Kardiologia Polska

Volumn 68, Issue 5, 2010, Pages 546-554

  Opolski, Grzegorz ^a   Kosior, Dariusz A ^a   Kurzelewski, Michał ^b   Skrzyńska, Małgorzata ^c   Zagórski, Aleksander ^d   Janion, Marianna ^e   Muzolf, Małgorzata ^f   Wlazłowski, Ryszard ^g   Pankiewicz, Barbara ^h   Łoboz Grudzień, Krystyna ⁱ   Breithardt, Günter ^j  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Sanofi Aventis Group Poland   (Poland)

^c Independent Public Health Care Centre   (Poland)

^d Private Office   (Poland)

^e Swietokrzyskie Centre of Cardiology   (Poland)

^f MEDICA Healthcare Centre   (Poland)

^g Hospital of the Hospitaller Brothers of St John of God   (Poland)

^h Cardiology Ward   (Poland)

ⁱ Marciniak Memorial Hospital   (Poland)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

more..

Author keywords

Atrial fibrillation; Rate control strategy; Registry; Rhythm control strategy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLAND; SINUS RHYTHM; STROKE; TRANSIENT ISCHEMIC ATTACK; VITAL SIGN;

EID: 77953760847     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Furberg CD, Psaty BM, Manolio TA et al. For the CHS Collaborative Research Group. Prevalence of Atrial Fibrillation in Eld erly Subject (The Cardiovascular Health Study). Am J Cardiol, 1994; 74: 236-241.
2. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med, 1995; 155: 469-473.
3. Steward S, Hart CL, Hole DJ et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley Study. Heart, 2001; 86: 516-521. (Pubitemid 32999861)
4. Stewart S, Hart CL, Hole DJ et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med, 2002; 113: 359-364.
5. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol, 2002; 155: 819-826.
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med, 1987; 147:1561-1564.
7. Savelieva I, Paquette M, Dorian P et al. Quality of life in patients with silent atrial fibrillation. Heart, 2001; 85: 216-217. (Pubitemid 32973598)
8. Dorian P, Jung W, Newman D et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implication for the assessment of the investigational therapy. J Am Coll Cardiol, 2000; 36: 1303-1309.
9. Wilson JS. Atrial fibrillation: a growth industry in the 21st century. Eur Heart J, 2000; 21: 1207-1208.
10. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation, 2004; 110: 1042-1046.
11. Wolff PA, Benjamin AJ, Belanger AJ et al. Secular trends in the prevalence of atrial fibrillation. The Framingham Study. Am Heart J, 1996; 131: 790-795.
12. Friberg J, Buch P, Scharling H et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology, 2003; 14: 666-672.
13. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol, 2006; 48: 149-246.
14. Le Heuzey J-Y, Breithardt G, Camm J et al. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol, 2010; 105: 687-693.
15. Breithardt G, Camm J, Crjins H et al. Differences in Patient Profiles and Management of Paroxysmal Atrial Fibrillation Compared to Persistent Atrial Fibrillation in the RecordAF Registry. ACC Abstract, March 2009.
16. http://www2.wum.edu.pl/kkk/ (access date: January 2007).
17. Friberg J, Scharling H, Gadsboll N et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol, 2003; 92: 1419-1423. (Pubitemid 37532563)
18. Goudevenos JA, Vakalis JN, Giogiakas V et al. An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece. Europace, 1999; 1: 226-233.
19. Kerr CR, Boone J, Connolly SJ et al. The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. Am J Cardiol, 1998; 82: 82N-85N.
20. Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med, 1995; 98: 476-484.
21. Levy S, Maarek M, Coumel P et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation, 1999; 99: 3028-3035.
22. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart, 2001; 86: 284-288.
23. Carlsson J, Tebbe U, Rox J et al. Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Am J Cardiol, 1996; 78: 1380-1384.
24. Frykman V, Beerman B, Ryden L et al. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J, 2001; 22: 1954-1959.
25. Nieuwlaat R, Capucci A, Camm JA et al. Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation. Eur Heart J, 2005; 26: 2422-2434.
26. Nabauer M, Gerth A, Limbourg T et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace, 2009; 11: 423-434.
27. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet, 1993; 341: 1317-1322.
28. Nieuwlatt R, Prins MH, Le Heuzey J-Y et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation. Eur Heart J, 2008; 29: 1181-1189.